These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14517833)

  • 1. The vascular network of tumours--what is it not for?
    Sivridis E; Giatromanolaki A; Koukourakis MI
    J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of angiogenesis in solid tumours: an overview.
    Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis: basic and clinical aspects.
    Ribatti D; Vacca A; Nico B; Presta M; Roncali L
    Ital J Anat Embryol; 2003; 108(1):1-24. PubMed ID: 12737512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the vascular component in growth of solid tumors: a historical review].
    Ribatti D; Vacca A
    Ann Ital Med Int; 1994; 9(2):92-5. PubMed ID: 7522501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour angiogenesis: vascular growth and survival.
    Giatromanolaki A; Sivridis E; Koukourakis MI
    APMIS; 2004; 112(7-8):431-40. PubMed ID: 15563307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lattice and non-lattice models of tumour angiogenesis.
    Plank MJ; Sleeman BD
    Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Oncogene; 2002 Feb; 21(9):1309-15. PubMed ID: 11857074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.
    McDougall SR; Anderson AR; Chaplain MA
    J Theor Biol; 2006 Aug; 241(3):564-89. PubMed ID: 16487543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in neuroblastoma.
    Ribatti D; Marimpietri D; Pastorino F; Brignole C; Nico B; Vacca A; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():133-42. PubMed ID: 15650239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
    Plank MJ; Sleeman BD; Jones PF
    J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour angiogenesis and response to radiotherapy.
    Koukourakis MI
    Anticancer Res; 2001; 21(6B):4285-300. PubMed ID: 11908683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
    Horsman MR; Siemann DW
    Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional models of tumour angiogenesis and anti-angiogenesis strategies.
    Orme ME; Chaplain MA
    IMA J Math Appl Med Biol; 1997 Sep; 14(3):189-205. PubMed ID: 9306674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of vascular stabilization for tumor growth and metastasis.
    Ergun S; Tilki D; Oliveira-Ferrer L; Schuch G; Kilic N
    Cancer Lett; 2006 Jul; 238(2):180-7. PubMed ID: 16084013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis.
    Sharma S; Sharma MC; Sarkar C
    Histopathology; 2005 May; 46(5):481-9. PubMed ID: 15842629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.